T Cell Responses to Cytomegalovirus Proteins in Healthy Subjects
Author Information
Author(s): Slezak Stefanie L, Bettinotti Maria, Selleri Silvia, Adams Sharon, Marincola Francesco M, Stroncek David F
Primary Institution: National Institutes of Health
Hypothesis
The study aims to characterize the T cell responses to CMV proteins pp65 and IE-1 in healthy subjects.
Conclusion
The study found that pp65 may be more effective than IE-1 for vaccine and immune therapies due to the higher prevalence of T cell responses.
Supporting Evidence
- 35% of subjects showed CD8+ T cell responses to pp65.
- 40% of subjects showed CD8+ T cell responses to IE-1.
- 50% of subjects showed CD4+ T cell responses to pp65.
Takeaway
Researchers looked at how healthy people's immune systems respond to parts of a virus called CMV, finding that one part (pp65) gets more reactions than another part (IE-1).
Methodology
The study used peptide pools and cytokine flow cytometry to analyze T cell responses in 20 healthy CMV-seropositive subjects.
Limitations
The study only included healthy subjects and did not assess responses in immunocompromised individuals.
Participant Demographics
{"age":{"median":45.1,"range":"17–64"},"gender":{"male_percentage":80},"race":{"white_percentage":55,"black_percentage":40,"hispanic_percentage":5}}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website